This affiliate content is not influenced by our advertising relationships, but AP and Data Skrive might earn commissions from ...

Cantor Fitzgerald initiated coverage of AST SpaceMobile (ASTS) with an Overweight rating and $30 price target The firm says AST’s strategic ...

AST SpaceMobile (ASTS – Research Report) received a Buy rating and a $30.00 price target from Cantor Fitzgerald analyst Colin Canfield today.

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of ...

AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's former senior executive Leon Wang and has provided information as needed, its ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one ...

It's an infuriating time for Dallas Mavericks fans, and a conflicting one for Kyrie Irving after the Luka Dončić trade.

Wall Street falls as Trump imposes tariffs, but not as badly as feared The threat of a punishing trade war sent Wall Street ...

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the ...

AstraZeneca PLC closed 15.78% below its 52-week high of £133.88, which the company achieved on September 3rd.

The pharmaceutical giant said it was no longer pursuing a £450 million investment in a vaccine manufacturing plant in ...

AstraZeneca will no longer invest 450 million pound ($558.3 million) at its vaccine manufacturing plant in northern England, the company said on Friday, citing a reduction in government support. The ...